Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01525797 · ClinicalTrials.gov registry record
Blood Draw Study for Liver Transplant Patients
A clinical trial, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 221
- Enrollment target
NCT01525797: Completed study, sponsored by Baylor Research Institute.
NCT01525797 is a clinical trial that has completed, run by Baylor Research Institute. The registered enrollment target is 221 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01525797 has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 221 participants
- Enrollment target
Study Summary
The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.
Primary Outcome
Analyze the pattern of gene expression in patients undergoing solid organ transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 221 participants |
| Start Date | 2002-10-15 |
| Est. Completion | 2013-10-04 |
What the finished NCT01525797 record still lists
NCT01525797 is an observational study that tracks outcomes without assigning an intervention. The registered 221 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01525797 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01525797 about?
NCT01525797 is a clinical study titled "Blood Draw Study for Liver Transplant Patients". The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.
What is the current status of trial NCT01525797?
This trial is currently completed. The enrollment target is 221 participants. The study started on 2002-10-15. Estimated completion is 2013-10-04.
Who is sponsoring clinical trial NCT01525797?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03170440 · 221 participants · NA
Non-invasive Nerve Stimulation for PTSD and Sleep
- NCT04939610 · 222 participants · Phase 1
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- NCT05424783 · 222 participants
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)
- NCT05568264 · 222 participants · NA
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI